EAG Advertising & Marketing

Bluestar Genomics, UChicago publish whole genome map of key biomarker for detecting cancer

A new whole-body tissue map of 5-hydroxymethylcytosine (5hmC) modifications was published, expanding understanding of a global biomarker for disease diagnosis. The map confirms 5hmC as a prevalent gene activation mark with superb tissue specificity, providing a resource for future diagnostic tests.

SourceEAG Advertising & Marketing·JournalNature Communications·DateDec 2, 2020

Nature Communications publishes Bluestar Genomics' technology for cancer detection study

Researchers developed a novel epigenomic approach to detect pancreatic cancer in its early stages using blood draws, identifying distinctive patterns in thousands of genes that serve as biomarkers. This technology has the potential to lead to more timely treatment and improved patient survival.

SourceEAG Advertising & Marketing·JournalNature Communications·DateOct 20, 2020